Table 1.
Overall (n = 3503) | |
---|---|
Age | 54.4 ± 9.7 |
Sex (male) | 61.80% |
Ethnicity | |
White | 50.40% |
Hispanic | 21.60% |
Asian | 8.80% |
Other | 19.20% |
Metabolic risk factors | |
Diabetes Type II | 27.30% |
Hypertension | 41.60% |
Hyperlipidemia | 12.20% |
Body Mass Index | 29.0 ± 6.8 |
Metabolic syndrome | 13.90% |
Significant history alcohol use | 46.30% |
Child Pugh Score | |
A | 44.10% |
BC | 55.90% |
Anti-viral therapy | 40.10% |
Achieved SVR | 33.40% |
Hepatocellular carcinoma (HCC) | |
Baseline HCC | 0% |
Hepatic Decompensation | |
Baseline decompensation | 49.90% |
Abbreviations: SVR, sustained virilogic response; HCC, hepatocellular carcinoma.